Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNC | P24863 | 1/20 | 0.44 |
| ▸ | CDK8 | P49336 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 3/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 7/20 | 0.40 |
| ▸ | CLK2 | P49760 | 6/20 | 0.40 |
| ▸ | CLK3 | P49761 | 5/20 | 0.40 |
| ▸ | CLK1 | P49759 | 3/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.40 |
| ▸ | DYRK1B | Q9Y463 | 3/20 | 0.40 |
| ▸ | CDK2 | P24941 | 3/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 2/20 | 0.39 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.39 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.39 |
| ▸ | WNT1 | P04628 | 3/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.38 |
| ▸ | CDK7 | P50613 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24137915 | 0.80 | JAK2 (0.57) | JAK2DYRK1ACLK2CLK3CLK4 | |
| SCHEMBL24137567 | 0.79 | DYRK1A (0.56) | CCNCCDK8FDPSJAK2DYRK1A | |
| SCHEMBL25938176 | 0.79 | CDK7 (0.45) | JAK2DYRK1ACLK2CLK3CLK4 | |
| SCHEMBL24137841 | 0.77 | JAK2 (0.61) | JAK2DYRK1ACLK2CLK3CLK4 | |
| SCHEMBL24137560 | 0.76 | CDK2 (0.57) | JAK2DYRK1ACLK4CDK2ROCK1 | |
| SCHEMBL25933932 | 0.75 | DYRK1A (0.50) | CCNCCDK8FDPSDYRK1ACLK2 | |
| SCHEMBL24137563 | 0.75 | CCNC (0.61) | CCNCCDK8FDPSJAK2DYRK1A | |
| SCHEMBL24137790 | 0.75 | CCNC (0.63) | CCNCCDK8DYRK1ACLK2CLK3 | |
| SCHEMBL24137792 | 0.74 | JAK2 (0.50) | JAK2DYRK1ACLK2CLK3CLK4 | |
| SCHEMBL10213915 | 0.74 | JAK2 (0.61) | JAK2DYRK1ACLK2CLK3CLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234935-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234935-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | PACSIN2, MAP3K20, PHKG1 | CCNC 571/4885CDK8 202/4885FDPS 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.